Always consult with a licensed healthcare provider before beginning any peptide therapy
10.1074/jbc.M114.550574[Epub ahead of print]
The mechanisms of TB-500 are still being investigated, but known actions of TB4 include: Binding as an actin-binding protein to inhibit the polymerization of globular actin (G-actin) into filamentous actin (F-actin), known as actin sequestration, which results in higher G-actin levels and increased cellular motility [23, 24] TB4s ability to increase cellular motility may help progenitor cells to reach sites of injury and initiate tissue recovery [25]
Tendon injuries Rotator cuff strains, tennis elbow, Achilles tendonitis, and patellar tendonitis respond well to BPC-157s ability to promote angiogenesis and collagen production in connective tissues
BPC-157 is not approved for human or veterinary use by the FDA, EMA, or any other regulatory authority
Looking forward to buying more soon